SLE patient visits using PDN, MMF, and HCQ as well as therapy combinations displayed no significant decrease of IFN score, STAT1, ADAR, pri-miR-146a, and mature miR-146a compared to untreated. The gene discussed is ADAR; the disease is systemic lupus erythematosus.